Product Highlight - Mercilon

Oral contraceptive pill with ultra-low-dose of estrogen
• A well-established and proven combined oral contraception that has been delivering reliable contraception for >30 years¹
• >99% efficacy with an ultra-low-dose of estrogen ^2,3
• Effective cycle control^2,3
• Good tolerability profile^2,3
• Neutral effect on weight²

References:
1. Lammers P and Op Ten Berg M. Phase III clinical trial with a new oral contraceptive containing 150 µg desogestrel and 20 µg ethinylestradiol. Acta Obstet Gynecol Scand. 1991;70:497-500.
2. Endrikat J, Cronin M, Gerlinger C. et al. Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 µg ethinyl estradiol and 75 µg gestodene and a 21-day regimen with 20 µg ethinyl estradiol and 150 µg desogestrel. Contraception. 2001;64:201-207.
3. Serfaty D and Vree ML. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 µg ethinylestradiol and either 150 µg desogestrel or 75 µg gestodene. The European Journal of Contraception & Reproductive Health Care. 1998;3(4):179-189.